Bangladesh’s regulation capping industrial trans-fatty acids (TFA) at 2 percent risks remaining largely unenforced due to critical gaps in laboratory capacity and inter-agency coordination, public health experts warned at a roundtable in Dhaka on Thursday.
The “Government-Industry Dialogue on Existing Gaps and Co-Creating Mitigation Solutions for TFA Reduction in Bangladesh” brought together regulators, scientists, development partners, and industry representatives. The discussion highlighted a growing “implementation gap” in enforcing the law, gazetted in 2021 and enforced from 2022.
An assessment of 13 public and private labs found that while many have advanced equipment like Gas Chromatography systems, most lack certified reference materials, validated methods, and standard operating procedures. As a result, test results are often inconsistent and legally indefensible, limiting regulatory action.
Imported edible oils containing 4–5 percent TFA—double the legal limit—continue entering the domestic market with minimal screening, experts said, undermining public health and penalizing compliant local producers.
“Our primary goal is to promote a healthier food environment by strengthening regulatory implementation,” said Professor Dr Mohammad Mostafa, Member (Public Health and Nutrition), BFSA. “The 2 percent TFA regulation is a major step, but it will only save an estimated 12,300 lives annually if fully enforced.”
Ummay Farihin Sultana of the Bangladesh NCD Forum highlighted the need for routine monitoring, data transparency, and stronger inter-agency coordination to meet national and global non-communicable disease targets.
Public health data presented at the session showed cardiovascular diseases account for nearly 59 deaths per 100,000 people in Bangladesh, with around 4 percent directly linked to trans-fat intake. “We are sitting on a time bomb,” one expert said, noting 66.7 percent of branded soybean oils still exceed WHO safe limits.
Professor Dr Mohammad Shoeb of BFSA warned of a “market misalignment,” where compliant local producers are disadvantaged by lax import monitoring. WHO’s Samina Israt stressed that laboratory hardware alone cannot ensure credible enforcement; trained personnel and standardized procedures are essential.
BFSA Chairman Zakaria said the biggest hurdle is fragmented communication between health, trade, and regulatory agencies. “Breaking these silos and creating an integrated monitoring system is essential,” he said.
Participants concluded that without urgent investment in laboratory capacity, skilled personnel, and coordinated oversight, Bangladesh’s trans-fat ban risks falling short, leaving a preventable public health threat unaddressed.